Longitudinal analysis of electrolyte prolife in intensive care COVID-19 patients

References

• Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020;76:97–99.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med CCLM. 2020;58(7):1131–1134.
   PubMed Web of Science ®Google Scholar
• Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med CCLM. 2020;58(7):1021–1028. DOI:10.1515/cclm-2020-0369
   PubMed Web of Science ®Google Scholar
• Tezcan ME, Dogan Gokce G, Sen N, et al. Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients. New Microbes New Infect. 2020;37:100753.
   PubMed Web of Science ®Google Scholar
• Rostami Z, Shafei S, Nemati E, et al. POS-109 COMMON ELECTROLYTE ABNORMALITIES in HOSPITALIZED COVID-19 PATIENTS. Kidney Int Rep. 2021;6(4):S45. DOI:10.1016/j.ekir.2021.03.117
   Google Scholar
• Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem Int J Lab Med. 2020;57(3):262–265.
   PubMed Web of Science ®Google Scholar
• Ravens U, Cerbai E. Role of potassium currents in cardiac arrhythmias. Europace. 2008;10(10):1133–1137.
   PubMed Web of Science ®Google Scholar
• DiNicolantonio JJ, O’keefe JH. Magnesium and Vitamin D deficiency as a potential cause of immune dysfunction, cytokine storm and disseminated intravascular coagulation in COVID-19 patients. Mo Med. 2021;118(1):68–73.
   PubMedGoogle Scholar
• Moreno-Pérez O, Leon-Ramirez J-M, Fuertes-Kenneally L, et al. Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: a case series of 306 Mediterranean patients. Int J Infect Dis. 2020;100:449–454.
   PubMed Web of Science ®Google Scholar
• Limaye CS, Londhey VA, Nadkart MY, et al. Hypomagnesemia in critically ill medical patients. J Assoc Physicians India. 2011;59:19–22.
   PubMedGoogle Scholar
• Atila C, Sailer CO, Bassetti S, et al. Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls. Eur J Endocrinol. 2021;184(3):413–422. DOI:10.1530/EJE-20-1374
   Google Scholar
• Liu S, Zhang L, Weng H, et al. Association between average plasma potassium levels and 30-day mortality during hospitalization in patients with COVID-19 in Wuhan, China. Int J Med Sci. 2021;18(3):736–743. DOI:10.7150/ijms.50965
   PubMed Web of Science ®Google Scholar
• van Kempen Tatg, Deixler E, van Kempen TATG. SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19. Am J Physiol Endocrinol Metab. 2021;320(1):E2–6.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med. 2020;52(7):345–353.
   PubMed Web of Science ®Google Scholar
• Noori M, Nejadghaderi SA, Sullman MJM, et al. How SARS-CoV-2 might affect potassium balance via impairing epithelial sodium channels? Mol Biol Rep. 2021;48(9):6655–6661. DOI:10.1007/s11033-021-06642-0
   PubMed Web of Science ®Google Scholar
• Zaika O, Mamenko M, Staruschenko A, et al. Direct activation of ENaC by angiotensin II: recent advances and new insights. Curr Hypertens Rep. 2013;15(1):17–24. DOI:10.1007/s11906-012-0316-1
   PubMed Web of Science ®Google Scholar
• Zimmer MA, Zink AK, Weißer CW, et al. Hypernatremia—a manifestation of COVID-19: a case series. A&A Practice. 2020;14(9):e01295. DOI:10.1213/XAA.0000000000001295
   PubMed Web of Science ®Google Scholar
• Bennouar S, Cherif AB, Kessira A, et al. Vitamin D deficiency and low serum calcium as predictors of poor prognosis in patients with severe COVID-19. J Am Coll Nutr. 2021;40(2):104–110. DOI:10.1080/07315724.2020.1856013
   PubMed Web of Science ®Google Scholar
• El-Kurdi B, Khatua B, Rood C, et al. Mortality from coronavirus disease 2019 increases with unsaturated fat and may be reduced by early calcium and albumin supplementation. Gastroenterology. 2020;159(3):1015–1018.e4. DOI:10.1053/j.gastro.2020.05.057
   PubMed Web of Science ®Google Scholar
• Tzoulis P, Waung JA, Bagkeris E, et al. Dysnatremia is a predictor for morbidity and mortality in hospitalized patients with COVID-19. J Clin Endocrinol Metab. 2021;107(6):1637–1648. dgab.
   Google Scholar
• Tan CW, Ho LP, Kalimuddin S, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. 2020;79–80:111017.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–184.
   PubMedGoogle Scholar
• Cai Q, Huang D, Yu H, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020;73(3):566–574. DOI:10.1016/j.jhep.2020.04.006
   PubMed Web of Science ®Google Scholar
• Redant S, Vanderhulst J, Maillart E, et al. Significance of hypernatremia due to SARS-CoV-2 associated ARDS in critically ill patients. J Transl Intern Med. 2020;8(4):255–260. DOI:10.2478/jtim-2020-0038
   PubMed Web of Science ®Google Scholar
• Lindner G, Funk G-C, Schwarz C, et al. Hypernatremia in the critically Ill is an independent risk factor for mortality. Am J Kidney Dis. 2007;50(6):952–957. DOI:10.1053/j.ajkd.2007.08.016
   PubMed Web of Science ®Google Scholar
• Darmon M, Timsit J-F, Francais A, et al. Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant. 2010;25(8):2510–2515. DOI:10.1093/ndt/gfq067
   PubMed Web of Science ®Google Scholar
• Casey J, Semler M, Rice T. Fluid management in acute respiratory distress syndrome. Semin Respir Crit Care Med. 2019;40(01):057–065.
   PubMedGoogle Scholar
• Pan X, Xu D, Zhang H, et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive care Med. 2020;46(6):1114–1116. DOI:10.1007/s00134-020-06026-1
   PubMed Web of Science ®Google Scholar
• Oren RM. Hyponatremia in congestive heart failure. Am J Cardiol. 2005;95(9):2–7.
   Google Scholar
• Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int. 1993;44(3):643–653.
   PubMed Web of Science ®Google Scholar
• de La Flor Jc, Gomez-Berrocal A, Marschall A, et al. Impacto de la corrección temprana de la hiponatremia en el pronóstico de la infección del síndrome respiratorio agudo grave del coronavirus 2 (SARS-CoV-2). Medicina Clínica. 2021;159(1):S0025775321004619. DOI:10.1016/j.medcli.2021.07.006
   Google Scholar
• Ohta M, Ito S. [Hyponatremia and inflammation]. Rinsho Byori. 1999;47(5):408–416.
   PubMedGoogle Scholar
• Swart RM, Hoorn EJ, Betjes MG, et al. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011;118(2):45–p51. DOI:10.1159/000322238
   PubMedGoogle Scholar
• Berni A, Malandrino D, Parenti G, et al. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J Endocrinol Invest. 2020;43(8):1137–1139. DOI:10.1007/s40618-020-01301-w
   PubMed Web of Science ®Google Scholar
• Melo AKG, Milby KM, Caparroz ALMA, et al. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis. PLoS ONE. 2021;16(6):e0253894. DOI:10.1371/journal.pone.0253894
   PubMed Web of Science ®Google Scholar
• Post A, Dullaart RPF, Bakker SJL. Sodium status and kidney involvement during COVID-19 infection. Virus Res. 2020;286:198034.
   PubMed Web of Science ®Google Scholar
• Benedetti C, Waldman M, Zaza G, et al. COVID-19 and the kidneys: an update. Front Med. 2020;7:423.
   Google Scholar
• Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):308–310.
   PubMed Web of Science ®Google Scholar
• Demirci T, Deshwal H, Goldenberg R. THE ‘CLOT’ THICKENS: hYPERKALEMIA DUE to ACUTE LIMB ISCHEMIA in COVID-19. Chest. 2021;160(4):A613.
   Web of Science ®Google Scholar
• Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–1032. DOI:10.1038/s41591-020-0968-3
   PubMed Web of Science ®Google Scholar
• Szabó GT, Kiss A, Csanádi Z, et al. Hypothetical dysfunction of the epithelial sodium channel may justify neurohumoral blockade in coronavirus disease 2019. ESC Heart Fail. 2021;8(1):171–174. DOI:10.1002/ehf2.13078
   PubMed Web of Science ®Google Scholar
• Matalon S, Bartoszewski R, Collawn JF. Role of epithelial sodium channels in the regulation of lung fluid homeostasis. Am J Physiol Lung Cell Mol Physiol. 2015;309(11):L1229–1238.
   PubMed Web of Science ®Google Scholar
• Sidhu K, Sanjanwala R, Zieroth S. Hyperkalemia in heart failure. Curr Opin Cardiol. 2020;35(2):150–155.
   PubMed Web of Science ®Google Scholar
• Aull L, Chao H, Coy K. Heparin-induced hyperkalemia. DICP Ann Pharmacother. 1990;24(3):244–246.
   PubMedGoogle Scholar
• Alfano G, Ferrari A, Fontana F, et al. Hypokalemia in patients with COVID-19. Clin Exp Nephrol. 2021;25(4):401–409. DOI:10.1007/s10157-020-01996-4
   PubMed Web of Science ®Google Scholar
• Chen D, Li X, Song Q, et al. Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China. JAMA Netw Open. 2020;3(6):e2011122. DOI:10.1001/jamanetworkopen.2020.11122
   PubMed Web of Science ®Google Scholar
• Nasomsong W, Ungthammakhun C, Phiboonbanakit D, et al. Low serum potassium among patients with COVID-19 in Bangkok, Thailand: coincidence or clinically relevant? Trop Doct. 2020;51(2):004947552097817. DOI:10.1177/0049475520978174
   Web of Science ®Google Scholar
• Tian Y, Rong L, Nian W, et al. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843–851. DOI:10.1111/apt.15731
   PubMed Web of Science ®Google Scholar
• Sun J-K, Zhang W-H, Zou L, et al. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging. 2020;12(12):11287–11295. DOI:10.18632/aging.103526
   PubMedGoogle Scholar
• Pal R, Ram S, Zohmangaihi D, et al. High prevalence of hypocalcemia in non-severe COVID-19 patients: a retrospective case-control study. Front Med. 2021;7:590805.
   Web of Science ®Google Scholar
• Kelly A, Levine MA. Hypocalcemia in the Critically Ill patient. J Intensive Care Med. 2013;28(3):166–177.
   PubMed Web of Science ®Google Scholar
• Pranata R, Supriyadi R, Huang I, et al. The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 Patients: a meta-analysis. Clin Med Insights: Circ Respir Pulm Med. 2020;14:117954842095916.
   Web of Science ®Google Scholar
• Di Filippo L, Formenti AM, Rovere-Querini P, et al. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine. 2020;68(3):475–478. DOI:10.1007/s12020-020-02383-5
   PubMed Web of Science ®Google Scholar
• Lind L, Carlstedt F, Rastad J, et al. Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med. 2000;28(1):93–99. DOI:10.1097/00003246-200001000-00015
   PubMed Web of Science ®Google Scholar
• Zaloga GP. The multifactorial basis for hypocalcemia during sepsis: studies of the parathyroid hormone-Vitamin D axis. Ann Intern Med. 1987;107(1):36.
   PubMed Web of Science ®Google Scholar
• Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLOS Pathog. 2014;10(5):e1004077. DOI:10.1371/journal.ppat.1004077
   PubMed Web of Science ®Google Scholar
• Cappellini F, Brivio R, Casati M, et al. Low levels of total and ionized calcium in blood of COVID-19 patients. Clin Chem Lab Med CCLM. 2020;58(9):e171–173. DOI:10.1515/cclm-2020-0611
   PubMed Web of Science ®Google Scholar
• Zhou Y, Frey TK, Yang JJ. Viral calciomics: interplays between Ca2+ and virus. Cell Calcium. 2009;46(1):1–17.
   PubMed Web of Science ®Google Scholar
• Singh VP, Khatua B, El-Kurdi B, et al. Mechanistic basis and therapeutic relevance of hypocalcemia during severe COVID-19 infection. Endocrine. 2020;70(3):461–462. DOI:10.1007/s12020-020-02530-y
   PubMed Web of Science ®Google Scholar
• Jafari Fesharaki M, Ahmadi N, Karimi Taheri K. Reversible heart failure in a patient with hypocalcemic cardiomyopathy. J Geriatr Cardiol JGC. 2021;18(12):1063–1067.
   PubMedGoogle Scholar
• Hurley K, Baggs D. Hypocalcemic cardiac failure in the emergency department. J Emerg Med. 2005;28(2):155–159.
   PubMed Web of Science ®Google Scholar
• Solzbach U, Kitterer H-R, Haas H. Reversible Herzinsuffizienz bei schwerer Hypokalzämie. Herz. 2010;35(7):507–511.
   PubMedGoogle Scholar
• Gomaa AA, Hassan HA, Ghaneimah SA. Effect of aspirin and indomethacin on the serum and urinary calcium, magnesium and phosphate. Pharmacol Res. 1990;22(1):59–70.
   PubMed Web of Science ®Google Scholar
• Quilliot D, Bonsack O, Jaussaud R, et al. Dysmagnesemia in Covid-19 cohort patients: prevalence and associated factors. Magnes Res. 2020;33(4):114–122. DOI:10.1684/mrh.2021.0476
   PubMed Web of Science ®Google Scholar
• Alamdari NM, Afaghi S, Rahimi FS, et al. Mortality risk factors among hospitalized COVID-19 patients in a major referral center in Iran. Tohoku J Exp Med. 2020;252(1):73–84. DOI:10.1620/tjem.252.73
   PubMed Web of Science ®Google Scholar
• Jiang P, Lv Q, Lai T, et al. Does hypomagnesemia impact on the outcome of patients admitted to the intensive care unit? a systematic review and meta-analysis. Shock. 2017;47(3):288–295. DOI:10.1097/SHK.0000000000000769
   PubMed Web of Science ®Google Scholar
• Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533–535. DOI:10.1038/s41423-020-0402-2
   PubMed Web of Science ®Google Scholar
• Jung S-Y, Kwon J, Park S, et al. Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy. PLoS ONE. 2018;13(2):e0191290. DOI:10.1371/journal.pone.0191290
   PubMed Web of Science ®Google Scholar
• Duan J, Wang X, Chi J, et al. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID‐19 in Chongqing. J Med Virol. 2020;92(11):2616–2622. DOI:10.1002/jmv.26082
   PubMed Web of Science ®Google Scholar
• Yousaf Z, Al-Shokri SD, Al-Soub H, et al. COVID-19-associated SIADH: a clue in the times of pandemic! Am J Physiol Endocrinol Metab. 2020;318(6):E882–885. DOI:10.1152/ajpendo.00178.2020
   PubMed Web of Science ®Google Scholar
• Mondal S, Das TK, Bhattacharya S, et al. Blood gas analysis among COVID-19 patients: a single centre retrospective observational study. J Clin Diagn Res. Epub ahead of print 2021. DOI:10.7860/JCDR/2021/49835.15185.
   Google Scholar
• Alfano G, Fontana F, Mori G, et al. Acid base disorders in patients with COVID-19. Int Urol Nephrol. Epub ahead of print 11 June 2021;54(2):405–410. DOI:10.1007/s11255-021-02855-1
   PubMed Web of Science ®Google Scholar